Robert Lim

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine · 2009 · 3.9K citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Hans‐Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero et al. · Journal of Clinical Oncology · 2006 · 298 citations

Medicine, Oncology, Pharmacology +17

The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using <i>In Vitro</i> Data in Lieu of a Clinical Trial

Anthony G. Durmowicz, Robert Lim, Hobart Rogers et al. · Annals of the American Thoracic Society · 2017 · 144 citations

Medicine, Pharmacology, Pharmacotherapy +16

Predictive biomarkers to improve treatment of metastatic colorectal cancer (mCRC): Outcomes with cetuximab plus FOLFIRI in the CRYSTAL trial

Claus Henning Köhne, D. Stroiakovski, Cr. Changchien et al. · Journal of Clinical Oncology · 2009 · 28 citations

Medicine, Oncology, Pharmacology +17

Outcomes of Adjuvant Chemoradiotherapy After a Radical Gastrectomy and a D2 Node Dissection for Gastric Adenocarcinoma

Cheng Nang Leong, Hans T. Chung, K M. Lee et al. · The Cancer Journal · 2008 · 26 citations

Medicine, Oncology, Surgery +17